Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TAO Synergies (TAOX) Liabilities and Shareholders Equity (2019 - 2026)

TAO Synergies filings provide 8 years of Liabilities and Shareholders Equity readings, the most recent being $31.0 million for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 102.54% to $31.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $95.0 million through Mar 2026, up 12.77% year-over-year, with the annual reading at $25.8 million for FY2025, 45.68% up from the prior year.
  • Liabilities and Shareholders Equity hit $31.0 million in Q1 2026 for TAO Synergies, up from $25.8 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $38.6 million in Q4 2022 and bottomed at $15.3 million in Q1 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $27.6 million, with a median of $29.4 million recorded in 2024.
  • The largest annual shift saw Liabilities and Shareholders Equity tumbled 47.86% in 2025 before it surged 102.54% in 2026.
  • TAO Synergies' Liabilities and Shareholders Equity stood at $38.6 million in 2022, then fell by 19.41% to $31.1 million in 2023, then plummeted by 43.0% to $17.7 million in 2024, then surged by 45.68% to $25.8 million in 2025, then rose by 20.18% to $31.0 million in 2026.
  • Per Business Quant, the three most recent readings for TAOX's Liabilities and Shareholders Equity are $31.0 million (Q1 2026), $25.8 million (Q4 2025), and $18.4 million (Q3 2025).